Biomedical Engineering Reference
In-Depth Information
Murray E, Lo B, Pollack L, Donelan K, Lee K (2003) Direct-to-consumer advertising: physicians'
views of its effects on quality of care and the doctor-patient relationship. J Am Board Fam Pract
16(6):513-524
Narayanan S, Desiraju R, Chintagunta PK (2004) Return on investment implications for
pharmaceutical promotional expenditures: the role of marketing-mix interactions. J Mark
68:90-105
Osinga EC, Leefl ang PSH, Srinivasan S, Wieringa JE (2010) Why do fi rms invest in consumer
advertising with limited sales response? A shareholder perspective. J Mark 75(1)
Palumbo FB, Mullins CD (2002) The development of direct-to-consumer prescription drug
advertising regulation. Food Drug Law J 57(3):423-443
Piani AL, Schoenbom CA (1993) Health promotion and disease prevention: United States, 1990.
Vital Health Stat 185:1-88
Pines WL (1999) A history and perspective on direct-to-consumer promotion. Food Drug Law J
54:491-507
Robinson AR, Hohmann KB, Rifkin JI, Daniel T, Gilroy CM, Pickard JA, Anderson RJ (2004)
Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential
effects on the physician-patient relationship. Arch Intern Med 164(4):427-432
Rosenthal MB, Berndt ER, Donohue JM, Epstein AM, Frank RG (2003) Demand effects of recent
changes in prescription drug promotion. Front Health Policy Res 6:1-26
Sethuraman R, Tellis G, Briesch R (2011) How well does advertising work? Generalizations from
a meta-analysis of brand advertising elasticity. J Mark Res 48(3):457-471
Stremersch S, Lemmens A (2009) Sales growth of new pharmaceuticals across the globe: the role
of regulatory regimes. Mark Sci 28(4):690-708
Stremersch S, Van Dyck W (2009) Marketing of the life sciences: a new framework and research
agenda for a nascent fi eld. J Mark 73(July):4-30
Streemersch S, Landsman V, Venkataraman S (2013) The relationship between DTCA, drug
requests, and prescriptions: Uncovering variation in specialty and space. Mark Sci 32(1):
89-110
Wilson RT, Till BD (2007) Direct-to-consumer pharmaceutical advertising: building and testing a
model for advertising effectiveness. J Advert Res 47(3):270-282
Wittink, Dick R (2002) Analysis of ROI for pharmaceutical promotions, unpublished study
conducted for the Association of Medical Publications
Wosinska M (2002) Just what the patient ordered? Direct-to-consumer advertising and the demand
for pharmaceutical products. HBS marketing research paper no. 02-04
Wosinska M (2005) Direct-to-consumer advertising and drug therapy compliance. J Mark Res
42:323-332
Young HN, Bell RA, Epstein RM, Feldman MD, Kravitz RL (2008) Physicians' shared
decision- making behaviors in depression care. Arch Intern Med 168(3):1404-1408
Search WWH ::
Custom Search